ArticleAdvances in cancer biology - metastasis2022

Novel plasma exosome biomarkers for prostate cancer progression in co-morbid metabolic disease.

Naser Jafari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.